Breast Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Plastic and Reconstructive Surgical Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
Br J Surg. 2023 Jun 12;110(7):831-838. doi: 10.1093/bjs/znad107.
Nipple-sparing mastectomy is associated with a higher risk of mastectomy skin-flap necrosis than conventional skin-sparing mastectomy. There are limited prospective data examining modifiable intraoperative factors that contribute to skin-flap necrosis after nipple-sparing mastectomy.
Data on consecutive patients undergoing nipple-sparing mastectomy between April 2018 and December 2020 were recorded prospectively. Relevant intraoperative variables were documented by both breast and plastic surgeons at the time of surgery. The presence and extent of nipple and/or skin-flap necrosis was documented at the first postoperative visit. Necrosis treatment and outcome was documented at 8-10 weeks after surgery. The association of clinical and intraoperative variables with nipple and skin-flap necrosis was analysed, and significant variables were included in a multivariable logistic regression analysis with backward selection.
Some 299 patients underwent 515 nipple-sparing mastectomies (54.8 per cent (282 of 515) prophylactic, 45.2 per cent therapeutic). Overall, 23.3 per cent of breasts (120 of 515) developed nipple or skin-flap necrosis; 45.8 per cent of these (55 of 120) had nipple necrosis only. Among 120 breasts with necrosis, 22.5 per cent had superficial, 60.8 per cent had partial, and 16.7 per cent had full-thickness necrosis. On multivariable logistic regression analysis, significant modifiable intraoperative predictors of necrosis included sacrificing the second intercostal perforator (P = 0.006), greater tissue expander fill volume (P < 0.001), and non-lateral inframammary fold incision placement (P = 0.003).
Modifiable intraoperative factors that may decrease the likelihood of necrosis after nipple-sparing mastectomy include incision placement in the lateral inframammary fold, preserving the second intercostal perforating vessel, and minimizing tissue expander fill volume.
与传统的保留皮肤的乳房切除术相比,保留乳头的乳房切除术与乳房皮瓣坏死的风险更高。目前,关于可改变的术中因素与保留乳头的乳房切除术后皮瓣坏死之间的关系的前瞻性数据有限。
记录了 2018 年 4 月至 2020 年 12 月期间连续接受保留乳头的乳房切除术的患者的数据。在手术时,乳腺外科医生和整形医生记录了相关的术中变量。在第一次术后就诊时记录乳头和/或皮瓣坏死的存在和程度。在手术后 8-10 周记录坏死的治疗和结果。分析了临床和术中变量与乳头和皮瓣坏死的关系,并将有意义的变量纳入向后选择的多变量逻辑回归分析。
299 例患者接受了 515 例保留乳头的乳房切除术(预防性 54.8%(282/515),治疗性 45.2%(233/515))。总体而言,515 例乳房中有 23.3%(120/515)发生乳头或皮瓣坏死;其中 45.8%(55/120)仅发生乳头坏死。在 120 例有坏死的乳房中,22.5%为表浅坏死,60.8%为部分坏死,16.7%为全层坏死。多变量逻辑回归分析显示,坏死的可改变术中预测因素包括牺牲第二肋间穿支(P=0.006)、更大的组织扩张器填充体积(P<0.001)和非外侧乳房下皱襞切口放置(P=0.003)。
可改变的术中因素,包括切口放置在外侧乳房下皱襞、保留第二肋间穿支血管和尽量减少组织扩张器填充体积,可能会降低保留乳头的乳房切除术后发生坏死的可能性。